ESC 365 - State-of-the-art lecture: are we ready to use genetic testing for risk stratification of sudden cardiac death?

ESC Professional Premium Access

State-of-the-art lecture: are we ready to use genetic testing for risk stratification of sudden cardiac death?

Session: Are we ready to use genetic testing for risk stratification of sudden cardiac death?

Topic: Epidemiology, Prognosis, Outcome

Speaker: Professor A. Wilde (Amsterdam, NL)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Professor Arthur Wilde

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

15 presentations

6 followers

3 more presentations in this session

Genetic factors predisposing to arrhythmic events and QTc prolongation during follow-up in long QT patients with unaffected QTc at initial presentation: Swedish experience

Speaker: Professor P. Platonov (Lund, SE)

Long-term outcomes in carriers of the familial idiopathic ventricular fibrillation linked to the DPP6 locus

Speaker: Mr A. Bergeman (Amsterdam, NL)

Arrhythmic risk stratification of filamin C truncating variants carriers

Speaker: Professor L. Mestroni (Aurora, US)

Access the full session

Are we ready to use genetic testing for risk stratification of sudden cardiac death?

Speakers: Professor A. Wilde, Professor P. Platonov, Mr A. Bergeman, Professor L. Mestroni

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

novartis

Explore sponsored resources